Jane Street Group, LLC My Md Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.22 - $0.58 $12,697 - $33,476	57,718 New	57,718 $15,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $5,367 - $198,759	2,418 Added 19.07%	15,099 $39,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $5,367 - $198,759	2,418 Added 19.07%	15,099 $39,000
Q2 2022 Aug 16, 2022	BUY	$2.0 - $4.78 $25,362 - $60,615	12,681 New	12,681 $28,000
Q1 2022 May 17, 2022	SELL	$3.34 - $6.05 $59,812 - $108,343	-17,908 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$5.46 - $9.69 $97,777 - $173,528	17,908 New	17,908 $109,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.